medications – Page 28 – Communicable Diseases Research

Case Report: Famotidine for Neuropsychiatric Symptoms in COVID-19

Medicine

Published on 2020-12-232022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

Global Infectious Disease Surveillance and Case Tracking System for COVID-19: Development Study

Original Paper

Published on 2020-12-222022-10-31
Journal: JMIR Medical Informatics [Category] COVID-19,

[키워드] addition affected application Blockchain Care Case report caused center Control country COVID-19 COVID-19 defense development disease transmission Diseases drug treatments effective effort facilitate global public health Health Health authority health care systems help HL7 FHIR hospital include Infectious disease Infectious disease surveillance information interface international collaboration interoperability Intervention labor-intensive laboratory data mechanisms medications new virus objective outcome pandemic Patient patient data patients with COVID-19 physician Physicians prevent disease spread prevention PROTECT provide receive recorded Research researcher respond Result reuse Spread Support Surveillance Symptoms System the disease Therapies this system transferred Transmission Treatment Trial utility virus was used
[DOI] 10.2196/20567 PMC 바로가기 [Article Type] Original Paper

Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis

Articles

Published on 2020-12-172022-10-31
Journal: International Journal of Environmental Research an [Category] COVID-19,

[키워드] 95% CI ACEi ACEIs Acute kidney injury acute respiratory distress Affair Affect Algorithm analyses angiotensin receptor blocker approach ARB ARBs association baseline blocker calibrated CCBs center Characteristics clinically Cohort cohort analysis Columbia University Combination combination therapy Comparisons Control COVID-19 COVID-19 diagnosis COVID-19 in patient data-driven decrease defined demonstrated Department determine development diuretics Effects Electronic health record enzyme European experiment finding funding generalisability generate hazard ratio heterogeneity hospital Hospital admission hypertension identify increased risk inhibitor International IQVIA janssen Korean lower risk Medical Research Council medications meta-analysed Ministry of Health monotherapy negative control network no significant difference observational study Older outcome partnership Patient patient cohort Pneumonia receiving Registered renin–angiotensin system risk risk of COVID-19 Sepsis South Spain susceptibility syndrome System Treatment USA user veteran Welfare Wellcome Trust with COVID-19
[DOI] 10.1016/S2589-7500(20)30289-2 PMC 바로가기 [Article Type] Articles

Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey

Observational Study

Published on 2020-12-042022-10-05
Journal: Nephrology, dialysis, transplantation : official p [Category] SARS, 임상,

[키워드] 95% CI 95% confidence interval adjusted Admission age Analysis chronic Chronic kidney disease CKD Comorbidities Comorbidity composed conducted control group COVID-19 COVID-19 infection COVID-19 patient COVID-19 treatment Factor female General population Haemodialysis HD group Hospitalized ICU admission Immunosuppression In-hospital in-hospital mortality in-hospital mortality rate increased risk Infection intensive care kidney Kidney disease Laboratory tests medications moderate morbidity and mortality Mortality much higher multicentre not significantly different outcome Patient patients patients died patients with COVID-19 potential risk quartile renal Renal transplantation retrospective severe coronavirus disease significantly higher small sample size Stage Turkey
[DOI] 10.1093/ndt/gfaa271 PMC 바로가기 [Article Type] Observational Study

Pharmacotherapy for Hospitalized Patients with COVID-19: Treatment Patterns by Disease Severity

COVID-19 입원 환자를 위한 약물 요법: 질병 중증도에 따른 치료 패턴

Article

Published on 2020-12-012022-09-11
Journal: Drugs [Category] SARS, 치료제,

[키워드] 95% confidence interval Anticoagulant co-morbidities coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 severity COVID-19 treatments defined determinant determinants disease severity driver Drivers dropped Electronic health record elevated evaluate Fever FIVE Health health record Healthcare system hospital Hospital admission Hospitalization Hospitalized identify inflammatory biomarkers intensive care intensive care unit Interpretation Intubated laboratory-confirmed Laboratory-confirmed COVID-19 level 1 medication medications minute morbidities Mortality non-randomized studies non-randomized study Other outcome oxygen oxygen saturation Patient patients hospitalized pattern pharmacological treatment pharmacotherapy predictor receive Remdesivir severity study period supplemental oxygen supportive care therapeutic treat Treatment
[DOI] 10.1007/s40265-020-01424-7 PMC 바로가기 [Article Type] Article

High sensitivity Troponin-T for prediction of adverse events in patients with COVID-19

COVID-19 환자의 부작용 예측을 위한 고감도 Troponin-T

Observational Study

Published on 2020-12-012022-08-31
Journal: Biomarkers : biochemical indicators of exposure, r [Category] MERS, SARS, 바이오마커, 임상,

[키워드] adverse event adverse events analysed Analysis Biomarker Cardiac arrest cardiac outcomes cardiac troponin clinical composite endpoint COVID-19 Critical care death demonstrated determine elevated events high risk identify In-hospital In-hospital death independent predictor independent predictors information initial intubation Laboratory medications Mortality multivariable analyses multivariable analysis Patient patients patients hospitalized patients with COVID-19 primary composite endpoint primary endpoint prognostic risk stratification sensitivity the median the primary endpoint troponin Troponin-T Univariable and multivariable analyses variable Vasoactive was performed were recorded with COVID-19
[DOI] 10.1080/1354750X.2020.1829056 PMC 바로가기 [Article Type] Observational Study

Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response

Research

Published on 2020-12-012022-10-31
Journal: Harm Reduction Journal [Category] COVID-19, MERS,

SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease

당뇨병 및 COVID-19 관련 신장 질환의 SARS-CoV-2 수용체 네트워크

Article

Published on 2020-12-012022-09-11
Journal: Kidney international [Category] SARS, 유전자 메커니즘,

[키워드] ACE ACE inhibitors ACE2 ACE2 expression ACE2 receptor acute kidney Acute kidney injury aldosterone Alter angiotensin Angiotensin-converting enzyme angiotensin-converting enzyme 2 Bayesian biopsy Cell cellular COVID-19 dataset diabetes Diabetic diabetic kidney diabetic nephropathy Donor endomembrane epithelial epithelial cell epithelial cells expression expression pattern expression patterns healthy hospitalized patient host cells immune activation In situ hybridization infected cells Infection inhibitor Integrative analysis investigated kidney kidney damage Kidney disease kidneys living donors mechanism medication medications molecular molecular networks morbidity morbidity and mortality overlapped Patient patients with diabete proximal proximal tubules Renin renin-angiotensin-aldosterone system Research risk stratification RNA SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 receptor SARS-CoV-2-infected cells scRNAseq susceptibility the SARS-CoV-2 Therapeutic strategies therapeutic strategy Urine Viral viral entry with COVID-19
[DOI] 10.1016/j.kint.2020.09.015 PMC 바로가기 [Article Type] Article

Associations of medications used during hospitalization and immunological changes in patients with COVID-19 during 3-month follow-up

입원 중 사용한 약물과 3개월 추적관찰 중 코로나19 환자의 면역학적 변화의 연관성

Article

Published on 2020-12-012022-09-11
Journal: International immunopharmacology [Category] MERS, SARS, 진단, 치료제,

[키워드] antibiotic use association CD3+ CD4+ CD4+ T cell CD4+ T cells CD8+ T cells changes in China completion COVID-19 COVID-19 patient COVID-19 patients declined decrease demonstrated discharge enrolled evaluate Follow-up glucocorticoid herd immunity Hospitalization IgG IgG and IgM IgM Immunity immunoglobulins immunological change immunological changes Immunological response immunological responses Increases increases in IQR Linear regressions median medication medications men Patient patients with COVID-19 positive rate positive rates Regression retrospective cohort study screened significantly increased T cell T cells understanding Vaccine was performed were used Wilcoxon signed-rank test with COVID-19 women
[DOI] 10.1016/j.intimp.2020.107121 PMC 바로가기 [Article Type] Article

Is there any potential management against COVID-19? A systematic review and meta-analysis

COVID-19에 대한 잠재적인 관리가 있습니까? 체계적인 검토 및 메타 분석

Meta-Analysis

Published on 2020-12-012022-09-11
Journal: Daru : journal of Faculty of Pharmacy, Tehran Univ [Category] 치료제,

[키워드] 95% CI 95% confidence interval Anakinra antiviral therapy article articles calculate Clinical effect Clinical improvement Clinical management convalescent plasma Convalescent plasma therapy COVID-19 COVID-19 infection COVID-19 pandemic Critical database declined Effect Efficacy eligibility criteria estimation Frequency had no Hydroxychloroquine ICU identify immunomodulator immunomodulators Immunomodulatory agent Immunomodulatory agents Improvements inception infected patients intensive care intensive care unit Intervention management mechanical ventilation medication medications Meta-analysis Mortality mortality rate Negative conversion no effect outcome outcomes Patient plasma plasma therapy Quantitative analysis random-effects model reduce Relative risk risk SARS-CoV-2 Scholar searched shown significantly standard treatment suggested systematic review therapy Tocilizumab Treatment was performed
[DOI] 10.1007/s40199-020-00367-4 PMC 바로가기 [Article Type] Meta-Analysis